1. Home
  2. QNRX vs CLWT Comparison

QNRX vs CLWT Comparison

Compare QNRX & CLWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

N/A

Current Price

$4.44

Market Cap

9.2M

Sector

Health Care

ML Signal

N/A

CLWT

Euro Tech Holdings Company Limited

N/A

Current Price

$1.48

Market Cap

9.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
QNRX
CLWT
Founded
2018
1971
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Professional and commerical equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
9.5M
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
QNRX
CLWT
Price
$4.44
$1.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
325.3K
1.2M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$17.56
Revenue Growth
N/A
N/A
52 Week Low
$3.25
$0.99
52 Week High
$41.80
$2.68

Technical Indicators

Market Signals
Indicator
QNRX
CLWT
Relative Strength Index (RSI) 49.98 49.03
Support Level $4.25 $1.13
Resistance Level $5.11 $1.63
Average True Range (ATR) 0.54 0.25
MACD 0.10 -0.02
Stochastic Oscillator 78.58 7.63

Price Performance

Historical Comparison
QNRX
CLWT

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is mainly a distributor of a wide range of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies, and power generation equipment, including recorders and power quality analyzers. The Company acts as an exclusive or non-exclusive distributor for manufacturers of such equipment to commercial customers and governmental agencies in Hong Kong and mainland China, as well as commercial customers in Macau. It has two operating segments: Trading and manufacturing, which generate maximum revenue and act as a distributor of water treatment equipment, laboratory instruments, analyzers, test kits, related supplies, and power generation equipment; and the Engineering segment. The Company generates maximum revenue from the PRC.

Share on Social Networks: